Primary care is often the first point of contact for people with emerging health concerns, making primary care physicians central to the early detection and long-term management of kidney disease. Early identification in these settings is critical, as many kidney diseases are diagnosed at later stages, while timely intervention can slow progression and improve outcomes. The ISN has...
Want quick, reliable references to guide multidisciplinary treatment decisions? The ISN Optimization of SGLT2i Therapy Toolkit provides handy infographics designed to help nephrologists, cardiologists, and other healthcare professionals optimize patient care across kidney, heart, and metabolic conditions. Access the tools in English, German, and Spanish Key topics covered include: Nuts and bolts of SGLT2i therapy at the...
The ISN is pleased to announce that the next ISN Frontiers Meeting will take place from September 5-7, 2026, in Dalian, China, co-organized with the Chinese Society of Nephrology (CSN)-Chinese Medical Association (CMA). Learn more and save the date This two-day global meeting will bring together leading experts, researchers, and clinicians to explore advances across four...
In October, 77 leading experts gathered in Amsterdam for the “ISN International Expert Forum: Exploring the Nexus of Cardio-Kidney-Metabolic Health,” a multidisciplinary meeting dedicated to shaping the future of cardio-kidney-metabolic (CKM) care. Over one and a half days of dynamic discussion, participants explored ways to overcome barriers in care delivery, strengthen health system integration,...
As we observe World Heart Day, today, September 29, the ISN underscores the critical intersection of cardiovascular and kidney health through its Cardio-Kidney-Metabolic (CKM) Initiative. The ISN encourages healthcare professionals worldwide to integrate the CKM tools into their practice. By doing so, clinicians can refine their approach to treating patients with overlapping cardiovascular, kidney, and...
Did you know the heart and kidneys are so closely connected that dysfunction in one can wreak havoc on the other? Explore this relationship and test your knowledge of cardiorenal syndrome in a new ISN Tweetorial. Access more resources on this topic through the ISN-led Cardio-Kidney-Metabolic (CKM) Initiative. The Tweetorial is supported by Boehringer Ingelheim.
“Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community,” a new joint commentary led by the ISN and partnering organizations, has been published in Kidney International Reports®, the American Journal of Preventive Cardiology, and ESC Heart Failure. Read the full commentary Although essential for managing chronic kidney disease, heart...
Are you making the most of the latest clinical tools from the multi-society Cardio-Kidney-Metabolic (CKM) Initiative led by the ISN? The CKM Initiative addresses gaps in therapy, management, and implementation — supporting clinicians and advancing care for patients with CKM conditions. It includes an interactive CKM roadmap to guide the management of patients with cardio-kidney-metabolic...
The ISN has expanded its “Cardio-Kidney-Metabolic (CKM) Initiative” with the launch of a new interactive CKM roadmap designed to help clinicians manage patients with cardio-kidney-metabolic conditions and complications. Access the roadmap here Kidney, cardiovascular, and metabolic diseases are closely linked, contributing significantly to morbidity and mortality worldwide. Launched in 2022, the CKM initiative brings nephrologists and...
